GUGüldem Utkan

Güldem Utkan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Güldem Utkan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The comparison of contribution of GO and rGO produced by green synthesis to the properties of CMC-based wound dressing material

    by Özge Gülüzar Karaca, Büşra Moran, Mustafa Türk, Ayça Bal-Öztürk, Burçin İzBudak, Yasar Andelib Aydin, Güldem Utkan, Neslihan Alemdar


  • Open Access

    Production of Reduced Graphene Oxide by Using Three Different Microorganisms and Investigation of Their Cell Interactions

    by Guldem Utkan, Gorkem Yumusak, Beste Cagdas Tunali, Tarik Ozturk, Mustafa Turk

    Despite the huge and efficient functionalities of reduced graphene oxide (RGO) for bioengineering applications, the use of harsh chemicals and unfavorable techniques in their production remains a major challenge. Microbial production of reduced graphene oxide (RGO) using specific bacterial strains has gained interest as a sustainable and efficient method. The reduction of GO to RGO by selected bacterial strains was achieved through their enzymatic activities and resulted in the removal of oxygen functional groups from GO, leading to the formation of RGO with enhanced structural integrity. The use of microorganisms offers a sustainable approach, utilizing renewable carbon sources and mild reaction conditions. This study investigates the production of RGO using three different bacterial strains: Lactococcus lactis (L. Lactis), Lactobacillus plantarum (L. plantarum), and Escherichia coli (E. coli) and evaluates its toxicity for safe utilization. The aim is to assess the quality of the produced RGO and evaluate its toxicity for potential applications. Thus, this study focused on the microbial production of reduced graphene oxides well as the investigation of their cellular interactions. Graphite-derived graphene oxide was used as a starting material and microbially reduced GO products were characterized using the FTIR, Raman, XRD, TGA, and XPS methods to determine their physical and chemical properties. FTIR shows that the epoxy and some of the alkoxy and carboxyl functional groups were reduced by E. coli and L. lactis, whereas the alkoxy groups were mostly reduced by L. plantarum. The ID/IG ratio from Raman spectra was found as 2.41 for GO. A substantial decrease in the ratio as well as defects was observed as 1.26, 1.35, and 1.46 for ERGO, LLRGO, and LPRGO after microbial reduction. The XRD analysis also showed a significant reduction in the interlayer spacing of the GO from 0.89 to 0.34 nm for all the reduced graphene oxides. TGA results showed that reduction of GO with L. lactis provided more reduction than other bacteria and formed a structure closer to graphene. Similarly, analysis with XPS showed that L lactis provides the most effective reduction with a C/O ratio of 3.70. In the XPS results obtained with all bacteria, it was observed that the C/O ratio increased because of the microbial reduction. Toxicity evaluations were performed to assess the biocompatibility and safety of the produced RGO. Cell viability assays were conducted using DLD-1 and CHO cell lines to determine the potential cytotoxic effects of RGO produced by each bacterial strain. Additionally, apoptotic, and necrotic responses were examined to understand the cellular mechanisms affected by RGO exposure. The results indicated that all the RGOs have concentration-dependent cytotoxicity. A significant amount of cell viability of DLD-1 cells was observed for L. lactis reduced graphene oxide. However, the highest cell viability of CHO cells was observed for L. plantarum reduced graphene oxide. All reduced graphene oxides have low apoptotic and necrotic responses in both cell lines. These findings highlight the importance of considering the specific bacterial strain used in RGO production as it can influence the toxicity and cellular response of the resulting RGO. The toxicity and cellular response to the final RGO can be affected by the particular bacterial strain that is employed to produce it. This information will help to ensure that RGO is used safely in a variety of applications, including tissue engineering, drug delivery systems, and biosensors, where comprehension of its toxicity profile is essential.


  • Open Access

    Effective Reduction of Graphene Oxide via Lactococcus lactis

    by Guldem Utkan

    In this study, bacteria Lactococcus lactis was employed as a bioreducing agent for ecofriendly and economical production of reduced graphene oxide at room temperature. Characterizations have showed that highly reduced graphene oxide was produced in mild conditions and layers have low number of wrinkles. Exfoliation by Lactococcus lactis has been succeeded to produce single or few layer reduced graphene oxide. Decrease in ratio of ID/IG from 2.15 to 0.97 calculated from Raman spectrum, decrease and/or disappearance of characteristic peaks of oxygen functional groups from FTIR, and changes observed in 2theta characteristic peak values at XRD spectrum have confirmed the reduction success of Lactococcus lactis. These results have indicated that Lactococcus lactis biomass could be employed as a new reductant to prevent the use of harmful chemicals and harsh conditions for reduced graphene oxide generation having high stability.


  • A novel PLED architecture containing biologically synthesized gold nanoparticles and ultra thin silver layer

    by Selin Pıravadılı Mucur, Emine Tekin, Sait Eren San, Özgür Duygulu, Hasan Ümit Öztürk, Güldem Utkan, Aziz Akın Denizci


  • Role of biomaterials in prevention of in‐stent restenosis

    by Nelisa T Laçin, Nelisa T., Guldem G. Utkan

    Coronary balloon angioplasty and coronary stenting are the procedures used in healing coronary artery disease. However, injury of arteries during angioplasty and stenting causes cell stimulations in tissue. Cell movement and thrombosis lead to re‐narrowing of widened vessel called restenosis. Several new types of carriers and technology have been developed to suppress and/or prevent restenosis. Authors review the polymeric materials featured in drug/gene carrier systems, nanovehicles, and stent coating materials against restenosis. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 1113–1120, 2014.


  • TIMP-2 gene transfer by positively charged PEG-lated monosized polycationic carrier to smooth muscle cells

    by Nelisa Laçin, Güldem Utkan, Tülin Kutsal, Bala Gür Dedeoğlu, Işık G. Yuluğ, Erhan Pişkin


  • A Thermo-Sensitive NIPA-Based Co-Polymer and Monosize Polycationic Nanoparticle for Non-viral Gene Transfer to Smooth Muscle Cells

    by Nelisa (Türkoğlu) Laçin, Güldem (Guven) Utkan, Tülin Kutsal, Erhan Pişkin

    Primary smooth muscle cells (SMC) isolated from the aorta of fetal calf were transfected with a green fluorescent protein (GFP)-encoding plasmid DNA, which was carried by a water-soluble and temperature-sensitive N-isopropylacrylamide-based (NIPAAm-based)-co-polymer, either poly(N-isopropylacrylamide-co-2-methacryloamidohistidine) (poly(NIPAAm-co-MAH)) or monosized PEGylated nanoparticle poly(styrene/poly(ethylene glycol) ethyl ether methacrylate/N-(3-(dimethylamino)propyl) methacrylamide) (poly(St/PEG-EEM/DMAPM)). Poly(NIPAAm-co-MAH) co-polymer was synthesized by solution polymerization of n-isopropylacrylamide (NIPAAm) and 2-methacrylamidohistidine (MAH). Monosized cationic nanoparticles were produced by emulsifier-free emulsion polymerization of styrene, PEG ethyl ether methacrylate and N-[3-(dimethyl-amino) propyl] methacrylamide, in the presence of a cationic initiator, 2,2-azobis (2-methylpropionamidine) dihydrochloride. The structure of poly(St/PEG-EEM/DMAPM) and poly(NIPAAm-co-MAH) was confirmed by1 H-NMR and FT-IR spectroscopy. Particle size/size distribution and surface charges of both carriers were measured by Zeta Sizer. The LCST behavior of poly(NIPAAm-co-MAH) co-polymer was followed spectrophotometrically. Poly(St/PEG-EEM/DMAPM) nanoparticles, with an average size of 78 nm and zeta potential of 54.4 mV, and an average size of 200 nm with a zeta potential of 54.2 mV, and poly(NIPAAm-co-MAH) were used in the transfection studies. The cytotoxicity of the vectors was tested using the MTT method. According to conditions for the transfection study (polymer/cell ratio and polymer–cell incubation period), cell loss was only 4 and 15% with poly(St/PEG-EEM/DMAPM) sized 78 and 200 nm, respectively. Poly(NIPAAm-co-MAH) cytotoxicity was insignificant. Poly(NIPAAm-co-MAH) uptake efficiency in SMCs was around 85%, but gene expression efficiency were low compared to poly(St/PEG-EEM/DMAPM)/pEGFP-N2 conjugates because of the low zeta potential of the co-polymer. Polymer uptake efficiencies of the nanoparticles were 90–95%. GFP expression efficiency was 68 and 64% after transfection with pEGFP-N2 conjugate with 78 and 200 nm sized poly(St/PEG-EEM/DMAPM) nanoparticles.


  • Synthesis and characterization of nanomagnetite particles and their polymer coated forms

    by Guldem (Guven) Utkan, Filiz Sayar, Pinar Batat, Semra Ide, Manfred Kriechbaum, Erhan Pişkin